Delivery Order SPE2DR25D1106-SPE2DR26FJB5F
- Not listed
- The Defense Logistics Agency awarded a $16,697.50 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed price, non-set-aside contract with a completion date of December 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine commonly used by the Department of Defense for military personnel and beneficiaries requiring immunization protection....
- The Defense Logistics Agency awarded a delivery order valued at $57,106.75 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, supporting the federal government's medical supply...
- The Defense Logistics Agency awarded a $24,702.56 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,671.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 24, 2025, with completion targeted for November 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the Defense Logistics Agency's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,044.10 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 18, 2025, with an ultimate completion date of November 19, 2025. TYPHIM VI is a typhoid vaccine product, and this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $6,205.62 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 28, 2025, with a completion date of December 1, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999 and extending through December 2026. The products will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $3,326.09 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 18, 2025, with completion scheduled for November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid conjugate vaccine used for immunization purposes within military and federal healthcare...
- The Defense Logistics Agency awarded a $13,358.00 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price contract, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $6,899 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid conjugate vaccine commonly used for military personnel and federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,759.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the company's role as a critical...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB5FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,287.54 to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML syringes on a firm fixed price basis. This non-set-aside contract was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, indicating this delivery supports the federal government's immunization supply chain requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp demonstrates substantial capability in fulfilling federal medical procurement requirements across multiple therapeutic domains through competitive awards with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 11/30/25 |